Achieve recently announced that the FDA accepted its cytisinicline New Drug Application for treatment of nicotine dependence for smoking cessation, with a PDUFA target action date of June 20, 2026.

You’ve seen this supereffective anti-smoking ad campaign on TV. You won’t see it again. Smoking is the leading cause of preventable death in the U.S., but a long-standing and effective anti-smoking ad ...

“Our results suggest that adults may be using nicotine pouches for harm reduction given that use is highest among those that ...

Public Health England (PHE, UK) has estimated that smoke-free nicotine alternatives are up to 95 per cent less harmful than ...

Detailed price information for Achieve Life Sciences Inc (ACHV-Q) from The Globe and Mail including charting and trades.

Some anti-drug campaigns work, while others are memorable but don't succeed in making people give up smoking or other ...

Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development ...

Former CDC Director Susan Monarez testifies to Senate about her work under HHS Secretary RFK Jr. following her controversial ...